European and Mexican vs US diagnostic extracts of Bermuda grass and cat in skin testing

Annals of Allergy, Asthma and Immunology

Volumn 106, Issue 5, 2011, Pages 421-428

  Larenas Linnemann, Désirée ^a   Cruz, Alfredo Arias ^b   Gutierrez, Isabel Rojo ^c   Rodriguez, Pablo ^b   Shah Hosseini, Kijawasch ^d   Michels, Alexandra ^d   Mösges, Ralph ^d  

^a LIVER RESEARCH UNIT   (Mexico)

^b HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

^c HOSPITAL JUÁREZ DE MÉXICO   (Mexico)

^d UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; BERMUDA GRASS EXTRACT; BIOLOGICAL PRODUCT; DIAGNOSTIC AGENT; UNCLASSIFIED DRUG;

ADULT; ALLERGY TEST; ARTICLE; BERMUDA GRASS; CAT; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; COUGHING; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG POTENCY; DRUG USE; DRUG WITHDRAWAL; EUROPE; FEMALE; GRASS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEXICO; PRIORITY JOURNAL; PROVOCATION TEST; PRURITUS; QUANTITATIVE DIAGNOSIS; SKIN TEST; UNITED STATES; URTICARIA; WHEEZING;

ADULT; ALLERGENS; ANIMALS; CATS; CYNODON; DOUBLE-BLIND METHOD; EUROPE; FEMALE; HUMANS; MALE; MEXICO; MIDDLE AGED; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; SKIN TESTS; THERAPEUTIC EQUIVALENCY; UNITED STATES; YOUNG ADULT;

EID: 79955622237     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2010.11.020     Document Type: Article

References (19)

1. Bernstein IL, Li JT, Bernstein DI, et al. Allergy diagnostic testing: an updated practice parameter. Ann Allergy Asthma Immunol. 2008;100(3 suppl 3):S1-S148. (Pubitemid 351409337)
2. Larenas-Linnemann D, Cox LS. European allergen extract units and potency: review of available information. Ann Allergy Asthma Immunol. 2008;100:137-145. (Pubitemid 351238549)
3. Becker WM, Vogel L, Vieths S. Standardization of allergen extracts for immunotherapy: where do we stand? Curr Opin Allergy Clin Immunol. 2006;6:470-475.
4. Larenas Linnemann D, Fogelbach GA, Cruz AA. Practice patterns in Mexican allergologists about skin tests with allergens during 2005-2006 [in Spanish]. Rev Alerg Mex. 2008;55:10-17.
5. Canonica GW. Sub-lingual immunotherapy: World Allergy Organization position paper 2009. Allergy.2009;64(suppl 91):1-59
6. Roder E, Berger MY, Hop WC, Bernsen RM, de Groot H, Gerth van Wijk R. Sublingual immunotherapy with grass pollen is not effective in symptomatic youngsters in primary care. J Allergy Clin Immunol. 2007;119:892-898. (Pubitemid 46527818)
7. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008;63(suppl 86):8-160.
8. Larenas-Linnemann D, Esch RE, Guidos-Fogelbach G, Rodriguez-Perez N. A comparison of in vitro potency between European and Mexican allergen extracts and US (CBER/FDA) reference extracts. Allergol Immunopathol (Madr). 2010;38:170-173.
9. Larenas-Linnemann D, Matta JJ, Shah-Hosseini K, Michels A, Mosges R. Skin prick test evaluation of Dermatophagoides pteronyssinus diagnostic extracts from Europe, Mexico, and the United States. Ann Allergy Asthma Immunol. 2010;104:420-425.
10. Allergen immunotherapy: a practice parameter second update. J Allergy Clin Immunol. 2007;120(3 suppl):S25-S85.
11. Nordic Council on Medicines. Registration of Allergenic Preparations: Nordic Guidelines. 2nd ed. Uppsala, Sweden: NLN Publications; 1989:1-34.
12. Dreborg S, Frew A. Allergen standardization and skin tests: EAACI Position Paper. Allergy. 1993;48(suppl 14):49-82.
13. Mosges R, Pasch N, Schlierenkamper U, Lehmacher W. Comparison of the biological activity of the most common sublingual allergen solutions made by two European manufacturers. Int Arch Allergy Immunol. 2006;139:325-329.
14. Pastorello EA, Incorvaia C, Ortolani C, et al. Studies on the relationship between the level of specific IgE antibodies and the clinical expression of allergy, I: definition of levels distinguishing patients with symptomatic from patients with asymptomatic allergy to common aeroallergens. J Allergy Clin Immunol. 1995;96(5 pt 1):580-587.
15. Zarei M, Remer CF, Kaplan MS, et al. Optimal skin prick wheal size for diagnosis of cat allergy. Ann Allergy Asthma Immunol. 2004;92:604-610. (Pubitemid 39243149)
16. Ewbank PA, Murray J, Sanders K, Curran-Everett D, Dreskin S, Nelson HS. A double-blind, placebo-controlled immunotherapy dose-response study with standardized cat extract. J Allergy Clin Immunol. 2003;111:155-161. (Pubitemid 36143307)
17. Nanda A, O'Connor M, Anand M, et al. Dose dependence and time course of the immunologic response to administration of standardized cat allergen extract. J Allergy Clin Immunol. 2004;114:1339-1344. (Pubitemid 39575887)
18. Frew AJ, Powell RJ, Corrigan CJ, Durham SR. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2006;117:319-325. (Pubitemid 43190146)
19. Sander I, Fleischer C, Meurer U, Bruning T, Raulf-Heimsoth M. Allergen content of grass pollen preparations for skin prick testing and sublingual immunotherapy. Allergy. 2009;64:1486-1492.